Talents — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Estrigenix Therapeuticsestrigenix.cominJul 2026
Estrigenix Therapeutics is a pharmaceutical company developing first-in-class therapeutics based on estrogen biology to treat and prevent hot flashes and dementia in post-menopausal women.
BiotechDigital HealthFemTechHealthtechWauwatosa, US
Bill Donaldson(Chief Executive Officer)Victoria R. Zellmer(Chief Executive Officer)Daniel Sem(Vice President of Business Development)William Donaldson(President & Senior Vice President of Chemistry)Karyn Frick(Chief Scientific Officer)Patricia Scheller(Executive Chair)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.